Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,221Revenue $M103Net Margin (%)-81.1Z-Score-3.6
Enterprise Value $M1,217EPS $-0.8Operating Margin %-64.5F-Score5
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)-81.3Higher ROA y-yY
Price/Book010-y EBITDA Growth Rate %0Quick Ratio1.2Cash flow > EarningsY
Price/Sales11.65-y EBITDA Growth Rate %0Current Ratio1.2Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-49.9Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)3ROE % (ttm)0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M107ROI % (ttm)0Gross Margin Increase y-yY

Gurus Latest Trades with MACK

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

MACK is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


MACK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Nielsen Ulrik B.Director 2015-04-20Sell40,000$12.884.19 view
Sullivan William A.CFO and Treasurer 2015-04-15Sell15,000$12.874.27 view
Stewart Edward J.SVP & Pres, Healthcare Sol 2015-04-15Sell8,000$12.794.93 view
Fehr Gordon J.Director 2015-04-13Sell20,000$133.23 view
Mulroy Robert J.President and CEO 2015-03-24Sell114,368$11.7114.6 view
PORTER MICHAEL EDirector 2015-03-24Buy5,000$11.714.7 view
PORTER MICHAEL EDirector 2015-03-20Buy5,000$11.7714.02 view
Nielsen Ulrik B.Director 2015-03-19Sell40,000$11.9712.11 view
Sullivan William A.CFO and Treasurer 2015-03-19Sell15,000$11.9712.11 view
Stewart Edward J.SVP & Pres, Healthcare Sol 2015-03-17Sell8,000$11.9512.3 view

Press Releases about MACK :

    Quarterly/Annual Reports about MACK:

    News about MACK:

    Articles On GuruFocus.com
    Weekly CEO Sells Highlight: Starbucks Corp, KD Supply Holdings Inc, Capital One Financial Corp, Merr Dec 14 2014 

    More From Other Websites
    First-in-Human Phase 1 Trial of MM-141 Demonstrates Activity in Biomarker Positive Patients Apr 21 2015
    First-in-Human Phase 1 Trial of MM-141 Demonstrates Activity in Biomarker Positive Patients Apr 21 2015
    Merrimack Announces Final Clinical Results for MM-302 Phase 1 Study Demonstrating Robust Activity in... Apr 20 2015
    Merrimack Announces Final Clinical Results for MM-302 Phase 1 Study Demonstrating Robust Activity in... Apr 20 2015
    We're diversified and robust: Merrimack CEO Apr 01 2015
    Merrimack to Highlight Extensive Oncology Pipeline at the 2015 American Association for Cancer... Mar 26 2015
    Merrimack to Highlight Extensive Oncology Pipeline at the 2015 American Association for Cancer... Mar 26 2015
    MERRIMACK PHARMACEUTICALS INC Financials Mar 06 2015
    MERRIMACK PHARMACEUTICALS INC Files SEC form 10-K, Annual Report Feb 27 2015
    Merrimack Pharmaceuticals Q4 Loss Narrower Than Expected - Analyst Blog Feb 27 2015
    Merrimack Pharmaceuticals Reports Fourth Quarter 2014 Financial Results Feb 26 2015
    Merrimack reports 4Q loss Feb 26 2015
    Merrimack reports 4Q loss Feb 26 2015
    Merrimack Pharmaceuticals' (MACK) Loss Narrows in Q4 - Tale of the Tape Feb 26 2015
    MERRIMACK PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Feb 26 2015
    Q4 2014 Merrimack Pharmaceuticals Inc Earnings Release - Before Market Open Feb 26 2015
    Merrimack Pharmaceuticals Reports Fourth Quarter 2014 Financial Results Feb 26 2015
    Merrimack Pharmaceuticals (MACK): A Miss this Earnings? - Analyst Blog Feb 24 2015
    Merrimack Pharmaceuticals Announces Initiation of a Phase 2 Biomarker-Selected Clinical Trial of... Feb 19 2015
    Merrimack Pharmaceuticals Announces Initiation of a Phase 2 Biomarker-Selected Clinical Trial of... Feb 19 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK